Designed for trade association, exhibitors, academic institutions and speakers, List and promote your online events
Largest database of verified shows since 2015, Detailed profiles of verified trade shows, conferences and consumer shows. Create your event and attract attendees and exhibitiors, Listing tools for verification, institution and corporation.
Connect with verified event organizers, Listing and RFP tools for verified venue operators.Size events by verified attendee and exhibitor count database
Research verified b2b events by industry and profession, Review virtual exhibitor showcase. Create Profile. Connect with verified event organizers and exhibitors.
Search 900k verified exhibitor database organizedby 2,000+ events since 2018.
Event Overview:
Considering drug safety in an isolated way, i.e., not integrating the drug benefits into a BR statement has been detrimental to patients and the pharmaceutical industry. Over the last years regulatory authorities, patient interest groups and the industry have become more and more interested in structured approaches to benefit risk management.
The change in the structure of the PSUR to a Periodic Benefit-Risk Evaluation Report complementing the Risk Management Plan is probably the most important example of how benefit-risk thinking is integrated into the lifecycle management of a drug. Several methodologies available for the qualitative and (semi-)quantitative analysis of benefit-risk profiles are going to be discussed, including their relative advantages and disadvantages. Finally, we are going to cover reasons why the decision framework for BR may change post-approval and how to address these changes in order to maintain a favorable BR balance.
Why should you Attend: The systematic assessment of a drug’s benefit-risk profile for the purpose of developing an integrated BR statement that helps in bringing a drug to the market and maintaining it there is a rather new challenge to the pharmaceutical industry triggered partially by a change in the format of periodic safety reports (PSUR) to Periodic Benefit-Risk Evaluation Reports (PBRER). Several methodologies for the development of such BR statements have been discussed and the choice of the "correct" one is not easy. A further challenge arises from the requirement to continuously re-assess the BR profile post-approval in an objective and transparent way. In this webinar we discuss ways to achieve a high-quality BR statement that satisfies the needs of regulators and aids patients and physicians in decision making about the use of a drug.
Areas Covered in the Session:
Who Will Benefit:
Contact Information:
Compliance4All
Phone: 800-447-9407
Fax: 302-288-6884
support@compliance4All.com
http://www.compliance4all.com
Event Link - http://bit.ly/1yHInWq
Source : Event Website
Event Name | City | State | Atendance | Exhibitors | Date |
---|---|---|---|---|---|
2023 NALP Leaders Forum - National Association of Landscape Professionals | Lahaina | Hawaii | estimated |
verified |
Jan 17, 2024 |
2024 Spring Shakopee Home Show | Shakopee | Minnesota | - | - | Jan 20, 2024 |
The Whole Bead Show January 2024 - Tucson | Tucson | Arizona | - | verified |
Jan 26, 2024 |
Home Improvement & Backyard Expo - January 2024 | Henderson | Nevada | estimated |
verified |
Jan 27, 2024 |
Omaha Home Show 2024 | Omaha | Nebraska | estimated |
verified |
Feb 01, 2024 |